The knockdown of eIF4AI interferes with the respiratory syncytial virus replication cycle

Acta Virol. 2021;65(4):433-439. doi: 10.4149/av_2021_411.

Abstract

The respiratory syncytial virus (RSV) is one of the main etiological agents in acute respiratory infections. To date, the replicative cycle of this virus is not completely known, and the events as well as the role of cellular and viral proteins that participate in the infectious cycle of RSV are still a matter of intense research. An important protein that is a control point for many viruses is the helicase eIF4AI, which participates at the beginning of the cap-dependent translation of eukaryotes and cap-independent translation of certain viral mRNAs. Recently, eIF4AI has been considered as a potential viral therapeutic target. In order to understand the role of eIF4AI during the infectious cycle of RSV, we evaluated the effect of eIF4AI knockdown on the amount of positive-strand viral RNA and viral progeny of this virus. Our results showed a decrease for both parameters, suggesting a possible involvement of eIF4AI during replicative cycle of RSV. In addition, using confocal microscopy, it was observed that eIF4AI colocalized with RSV viral protein, supporting the possible participation of eIF4AI during the replicative cycle of RSV. Keywords: eIF4AI; RSV; translation; antiviral.

MeSH terms

  • Antiviral Agents / pharmacology
  • Humans
  • Respiratory Syncytial Virus Infections*
  • Respiratory Syncytial Virus, Human* / genetics
  • Viral Proteins
  • Virus Replication

Substances

  • Antiviral Agents
  • Viral Proteins